Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$6.05 - $9.74 $7.7 Million - $12.4 Million
1,273,356 Added 953.84%
1,406,854 $10.3 Million
Q4 2023

Feb 14, 2024

SELL
$3.29 - $6.64 $62,608 - $126,359
-19,030 Reduced 12.48%
133,498 $827,000
Q3 2023

Nov 14, 2023

BUY
$3.3 - $4.83 $503,342 - $736,710
152,528 New
152,528 $622,000
Q1 2023

May 15, 2023

BUY
$2.68 - $4.79 $688,301 - $1.23 Million
256,829 Added 69.52%
626,281 $3 Million
Q4 2022

Feb 14, 2023

BUY
$1.22 - $2.85 $319,385 - $746,104
261,791 Added 243.16%
369,452 $1.05 Million
Q3 2022

Nov 14, 2022

BUY
$0.59 - $1.44 $58,275 - $142,231
98,772 Added 1111.17%
107,661 $128,000
Q2 2022

Aug 15, 2022

SELL
$0.51 - $1.17 $116,025 - $266,175
-227,500 Reduced 96.24%
8,889 $5,000
Q1 2022

May 16, 2022

SELL
$0.65 - $1.18 $237,517 - $431,184
-365,411 Reduced 60.72%
236,389 $253,000
Q4 2021

Feb 14, 2022

BUY
$0.86 - $1.7 $517,548 - $1.02 Million
601,800 New
601,800 $662,000
Q2 2021

Aug 16, 2021

SELL
$6.55 - $8.98 $341,877 - $468,711
-52,195 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$6.1 - $7.69 $133,864 - $168,757
21,945 Added 72.55%
52,195 $346,000
Q4 2020

Feb 16, 2021

SELL
$5.05 - $7.1 $3,050 - $4,288
-604 Reduced 1.96%
30,250 $196,000
Q3 2020

Nov 16, 2020

BUY
$5.25 - $7.08 $161,983 - $218,446
30,854 New
30,854 $162,000
Q2 2020

Aug 14, 2020

SELL
$5.37 - $8.11 $396,649 - $599,037
-73,864 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$4.35 - $8.79 $191,500 - $386,962
44,023 Added 147.53%
73,864 $420,000
Q4 2019

Feb 14, 2020

BUY
$4.23 - $8.29 $32,600 - $63,891
7,707 Added 34.82%
29,841 $224,000
Q3 2019

Nov 14, 2019

BUY
$2.15 - $6.28 $47,588 - $139,001
22,134 New
22,134 $104,000
Q3 2018

Nov 14, 2018

SELL
$3.75 - $4.65 $120,997 - $150,036
-32,266 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$3.7 - $5.8 $75,694 - $118,656
20,458 Added 173.26%
32,266 $119,000
Q1 2018

May 15, 2018

SELL
$5.05 - $7.9 $4,984 - $7,797
-987 Reduced 7.71%
11,808 $60,000
Q4 2017

Feb 14, 2018

BUY
$4.85 - $7.8 $62,055 - $99,801
12,795
12,795 $84,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.